Olga Kryštůfková researcher
Kryštůfková, Olga, 1955-
VIAF ID: 85676887 (Personal)
Permalink: http://viaf.org/viaf/85676887
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
A1.48 Enhanced expression of CD11c on non-classical CD16+peripheral blood monocytes in early rheumatoid arthritis | |
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study | |
Anti-Ro52 epitope mapping in inflammatory myopathies | |
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. | |
Effect of intravenous immunoglobulins on in vitro immunoglobulin formation in patients with antibody immunodeficiency | |
Endogenous HLA–DR–restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint | |
Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema | |
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies | |
The expression regulation of the HSPA1B gene in patients with myositis is not dependent on the presence of HLA-DRB1*03 risk allele | |
FRI0520 Association Study of the BAFF Genetic Variations in Two Independent Cohorts with Idiopathic Inflammatory Myopathies | |
Genetic variation in promoter sequence of B cell-activating factor gene is associated with increased risk of myositis development | |
Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. | |
The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy | |
Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis | |
No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene | |
Serum levels of interferon do not correlate with disease activity in patients with dermatomyositis/polymyositis | |
Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study |